Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J2426
    Short Description Inj, invega sustenna, 1 mg
    Long Description Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
    Pricing indicator 51
    Coverage code C
    ASC payment group code YY
    BETOS2 code O1E
    Action code N
    Type of service 1
    Effective date 2023-07-01
    Date Added 2011-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    50458056001 J2426 Inj, invega sustenna, 1 mg INVEGA SUSTENNA JANSSEN PHARMACEUTICALS, INC. 1 MG 0.25 1 39 39
    50458056101 J2426 Inj, invega sustenna, 1 mg INVEGA SUSTENNA JANSSEN PHARMACEUTICALS, INC. 1 MG 0.5 1 78 78
    50458056201 J2426 Inj, invega sustenna, 1 mg INVEGA SUSTENNA JANSSEN PHARMACEUTICALS, INC. 1 MG 0.75 1 117 117
    50458056301 J2426 Inj, invega sustenna, 1 mg INVEGA SUSTENNA JANSSEN PHARMACEUTICALS, INC. 1 MG 1 1 156 156
    50458056401 J2426 Inj, invega sustenna, 1 mg INVEGA SUSTENNA JANSSEN PHARMACEUTICALS, INC. 1 MG 1.5 1 234 234
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].

    HCPCS Billing Calculator

    Dosage given to patient (per dose)
    HCPCS Dosage 1 MG
    HCPCS/CPT Billing Units 1
    Total doses ordered
    Billing Units 1

    Drug Details

    • Paliperidone extended-release injections (Invega Hafyera, Invega Sustenna, Invega Trinza) are used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Paliperidone extended-release injection (Invega Sustenna) is also used alone or with other medications to treat schizoaffective disorder (a mental illness that causes both a loss of contact with reality and mood problems [depression or mania]). Paliperidone extended-release injection is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.